Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. is A member enterprise of "Guangzhou Baiyunshan Pharmaceutical Group Co., LTD.", a listed company controlled by Guangzhou Pharmaceutical Group (listed on both the Hong Kong H-share and Shanghai A-share). Its predecessor was the Guangzhou Xingqun Traditional Chinese Medicine Refinery, which was established in 1950 and was the first in China to modernize traditional Chinese medicine. Its history can be traced back to the Huang Xianghua Pharmaceutical Factory in 1868. After years of continuous innovation and development, it has now become a modern pharmaceutical and health enterprise with 11 major dosage forms including granules, soft capsules, oral solutions, liniments, tinctures and syrups, over 600 employees, an annual sales volume of nearly 500 million yuan and an annual tax and profit of over 60 million yuan. In recent years, it has successively won honors such as the first batch of "Chinese Enterprises", "Trustworthy Enterprise of China Customs", "Quality Management Award", "High-tech Enterprise", "National Contract-abiding and Creditworthy Enterprise", and "Intellectual Property Advantage Enterprise".

The company's main representative products include: Xia Sangju Granules, the first of its kind in China and a product of Guangdong Province and Guangzhou City, a product of the Guangdong Pharmaceutical industry, a cultural heritage of Lingnan traditional Chinese medicine in Guangdong Province, Ertianyou Granules, a product of Guangzhou City, a protective product of traditional Chinese medicine, a product of Guangdong Province, Anshen Bunao Liquid, as well as Alfasalcitol Capsules, Compound Licorice Oral Solution, Vitamin E Soft Capsules, etc. The products sell well throughout the country and are exported to America, Southeast Asia and other regions.

Baiyunshan Xingqun Xia Sangju has been trusted by consumers for many years. After nearly four decades of large-scale and modern production, its cumulative sales have exceeded 11 billion small packages, benefiting 11 billion people at home and abroad. The average annual sales revenue of the product has reached 200 million yuan. Xingqun Company has always adhered to the principle of inheriting the essence and upholding innovation. While vigorously developing its core pharmaceutical business, it has actively ventured into the medical and health industry, successively launching a series of health products including food, mineral water, health supplements, cosmeceuticals, and health beverages, which have been recognized and welcomed by the market.

Baiyunshan Xingqun Company has a glorious tradition of innovation. At a time when New China was in the process of rebuilding everything, it pioneered the trend of modernizing traditional Chinese medicine. It was the first in the country to create traditional Chinese medicine extracts and plant medicine purification, the first in the country to use the pressing method to prepare soft capsules, and the first in the country to successfully develop granular granules. The innovative and creative genes it has cultivated have continuously led the development of traditional Chinese medicine culture.